Chinese scientists use supercomputer to cut new drug screening time from years to seconds

Chinese scientists have developed an AI platform called GalaxyVS that uses a supercomputer to screen chemical compounds for drug discovery, reducing the initial screening phase from years to seconds. The system aims to accelerate research for treating tumors, neurodegenerative conditions, rare diseases, and emerging infectious diseases, particularly during public health crises.